STOCK TITAN

Bio-Techne Corp - TECH STOCK NEWS

Welcome to our dedicated page for Bio-Techne news (Ticker: TECH), a resource for investors and traders seeking the latest updates and insights on Bio-Techne stock.

Bio-Techne Corporation (NASDAQ: TECH) provides this centralized hub for investors and industry professionals tracking developments in life sciences innovation. Access official press releases, financial disclosures, and strategic updates from the global leader in bioactive reagents and diagnostic solutions.

This resource delivers timely updates on earnings results, product launches, and strategic collaborations critical to understanding the company's position in biotechnology markets. Users will find announcements related to protein analysis advancements, spatial biology innovations, and global distribution partnerships.

All content is sourced directly from Bio-Techne's corporate communications, ensuring accuracy for those monitoring investment opportunities or industry trends. Bookmark this page for efficient access to material developments affecting TECH's market performance and scientific impact.

Rhea-AI Summary
Bio-Techne Corporation (TECH) to present at the 6th Annual Evercore ISI HealthCONx Conference. The company is a leading developer and manufacturer of high-quality purified proteins, reagent solutions, and diagnostic products, generating approximately $1.1 billion in net sales in fiscal 2023 with approximately 3,200 employees worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.73%
Tags
conferences
-
Rhea-AI Summary
Bio-Techne Corporation (NASDAQ: TECH) to Present at Investor Healthcare Conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
conferences
-
Rhea-AI Summary
Bio-Techne Corporation (NASDAQ:TECH) announces Asuragen's presentation of new clinical laboratory testing solutions at the upcoming AMP meeting, focusing on cystic fibrosis variant detection, cancer monitoring, and resolving conventionally inaccessible disease-causing genes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.88%
Tags
conferences
Rhea-AI Summary
Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2023. First quarter organic revenue increased by 2% to $276.9 million. GAAP earnings per share (EPS) was $0.31 versus $0.55 one year ago. Adjusted EPS was $0.41 compared to $0.45 one year ago. ExoDx prostate test volume increased 49% and revenue increased 39%. ProteinSimple branded portfolio grew 9% in the quarter and 18% excluding China. Cash flow generated from operations increased to $59.4 million, a 6% increase from the prior year. Kim Kelderman was appointed as CEO effective February 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.55%
Tags
-
News
Rhea-AI Summary
Bio-Techne Corporation (NASDAQ: TECH) has announced a dividend payout of $0.08 per share for the quarter ended September 30, 2023. The dividend will be payable on November 24, 2023, to all common shareholders of record on November 10, 2023. Future cash dividends will be considered on a quarterly basis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.55%
Tags
dividends
-
Rhea-AI Summary
Bio-Techne's brand, Lunaphore, will showcase its technologies at the Society for Immunotherapy of Cancer's Annual Meeting. The presentations will highlight the capabilities of the COMET™ product suite in addressing complex biological questions. The symposia and poster presentations will focus on the optimization of anti-cancer therapy approaches and the mapping of immune and tumoral cells. Lunaphore's scientists will provide live demonstrations of the COMET™ system at the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.69%
Tags
conferences
Rhea-AI Summary
Bio-Techne Corporation appoints Kim Kelderman as President and CEO, effective February 1, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.24%
Tags
management
-
Rhea-AI Summary
Bio-Techne Corporation's Wallingford facility receives ISO 13485:2023 certification for its quality management system, demonstrating commitment to clinical applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
none
-
Rhea-AI Summary
Bio-Techne Corporation to host conference call on October 31, 2023 to announce first quarter fiscal 2024 financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.16%
Tags
conferences earnings
Rhea-AI Summary
Dr. Jordan Laser of Bio-Techne Corporation receives AMP Meritorious Service Award for his dedication and effort in positioning AMP as a premier molecular diagnostics association.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
Bio-Techne Corp

Nasdaq:TECH

TECH Rankings

TECH Stock Data

7.60B
156.43M
1.05%
101.12%
3.33%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
MINNEAPOLIS